Published in Tob Control on April 01, 2007
Cigarettes sold in China: design, emissions and metals. Tob Control (2010) 1.18
Chinese "herbal" cigarettes are as carcinogenic and addictive as regular cigarettes. Cancer Epidemiol Biomarkers Prev (2009) 1.13
Smoking in China: findings of the 1996 National Prevalence Survey. JAMA (1999) 8.67
Estimates of global and regional smoking prevalence in 1995, by age and sex. Am J Public Health (2002) 4.22
The dark side of marketing seemingly "Light" cigarettes: successful images and failed fact. Tob Control (2002) 4.05
Learning from Philip Morris: Japan Tobacco's strategies regarding evidence of tobacco health harms as revealed in internal documents from the American tobacco industry. Lancet (2004) 3.91
Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine. Mayo Clin Proc (2002) 2.67
Economic burden of smoking in Korea. Tob Control (2003) 1.99
Eyes on the prize: transnational tobacco companies in China 1976-1997. Tob Control (2000) 1.86
Breaking and re-entering: British American Tobacco in China 1979-2000. Tob Control (2004) 1.67
Political economy of tobacco control in Thailand. Tob Control (2001) 1.65
The marketing of menthol cigarettes in the United States: populations, messages, and channels. Nicotine Tob Res (2004) 1.54
Traditional Chinese medicine. Med Clin North Am (2002) 1.22
New tobacco products: do smokers like them? Tob Control (2006) 1.21
The US tobacco control community's view of the future of tobacco harm reduction. Tob Control (2003) 1.20
The impact of the cigarette market opening in Taiwan. Tob Control (2005) 1.10
Efficacy of polyphenon E, red ginseng, and rapamycin on benzo(a)pyrene-induced lung tumorigenesis in A/J mice. Neoplasia (2006) 1.06
Community tobacco control leaders' perceptions of harm reduction. Tob Control (2004) 1.06
ARTIST (Asian regional tobacco industry scientist team): Philip Morris' attempt to exert a scientific and regulatory agenda on Asia. Tob Control (2004) 1.06
The prevention of lung cancer induced by a tobacco-specific carcinogen in rodents by green and black Tea. Proc Soc Exp Biol Med (1999) 0.98
Effect of a 4-month tea intervention on oxidative DNA damage among heavy smokers: role of glutathione S-transferase genotypes. Cancer Epidemiol Biomarkers Prev (2004) 0.95
A "clean cigarette" for a clean nation: a case study of Salem Pianissimo in Japan. Tob Control (2004) 0.89
Policy and politics of smoking control in Japan. Soc Sci Med (1999) 0.86
Anticholinergic poisoning due to Chinese herbal medicines. Vet Hum Toxicol (1995) 0.84
Chinese Herbal Medicine in the treatment of acute respiratory tract infections: review of randomized and controlled clinical trials. Clin Infect Dis (1999) 0.79
[Effects of some Chinese herbal medicine and green tea antagonizing mutagenesis caused by cigarette tar]. Zhonghua Yu Fang Yi Xue Za Zhi (1997) 0.78
Tobacco industry strategies for influencing European Community tobacco advertising legislation. Lancet (2002) 4.38
Association of active and passive smoking with risk of breast cancer among postmenopausal women: a prospective cohort study. BMJ (2011) 2.80
Tobacco industry attempts to counter the World Bank report Curbing the Epidemic and obstruct the WHO framework convention on tobacco control. Soc Sci Med (2008) 1.99
Association of the California tobacco control program with declines in lung cancer incidence. Cancer Causes Control (2004) 1.95
Tobacco control policies are egalitarian: a vulnerabilities perspective on clean indoor air laws, cigarette prices, and tobacco use disparities. Soc Sci Med (2009) 1.49
The nature, scope, and development of the global tobacco control epistemic community. Am J Public Health (2011) 1.32
Tobacco industry sociological programs to influence public beliefs about smoking. Soc Sci Med (2008) 1.27
Clean indoor air laws immediately reduce heart attacks. Prev Med (2007) 1.25
Concentrations of the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in sidestream cigarette smoke increase after release into indoor air: results from unpublished tobacco industry research. Cancer Epidemiol Biomarkers Prev (2007) 1.24
Electronic cigarettes. Cardiology patient page. Circulation (2014) 1.18
The effect of tobacco control measures during a period of rising cardiovascular disease risk in India: a mathematical model of myocardial infarction and stroke. PLoS Med (2013) 1.04
Interaction between smoking and obesity and the risk of developing breast cancer among postmenopausal women: the Women's Health Initiative Observational Study. Am J Epidemiol (2011) 1.01
Smoking cessation, weight gain, and risk of type 2 diabetes mellitus among postmenopausal women. Arch Intern Med (2012) 0.99
Smoking and diabetes: does the increased risk ever go away? Am J Epidemiol (2013) 0.98
Effect of the Arizona tobacco control program on cigarette consumption and healthcare expenditures. Soc Sci Med (2010) 0.96
Scientific analysis of second-hand smoke by the tobacco industry, 1929-1972. Nicotine Tob Res (2005) 0.95
Knowledge and use of tobacco among Guatemalan physicians. Cancer Causes Control (2002) 0.84
The changing role of agriculture in tobacco control policymaking: a South Carolina case study. Soc Sci Med (2010) 0.80
Secondhand smoke and cardiologists: the missing link. Int J Cardiol (2004) 0.79
Response to letter regarding article, "Electronic cigarettes: a scientific review". Circulation (2015) 0.78
Strong tobacco control program requirements and secure funding are not enough: lessons from Florida. Am J Public Health (2012) 0.78
Debate over tobacco and film ratings should be evidence-based. N Z Med J (2013) 0.75
Tobacco Industry Influence on the American Law Institute's Restatements of Torts and Implications for Its Conflict of Interest Policies. Iowa Law Rev (2012) 0.75
Health conventions in smoke free places have positive economic impact. BMJ (2004) 0.75